Get the Stockscreener App
4.33
4.20%
-0.19
After Hours:
4.17
-0.16
-3.70%
Vivos Therapeutics Inc stock is traded at $4.33, with a volume of 132.33K.
It is down -4.20% in the last 24 hours and up +37.03% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$4.52
Open:
$4.44
24h Volume:
132.33K
Relative Volume:
0.19
Market Cap:
$25.50M
Revenue:
$14.58M
Net Income/Loss:
$-12.57M
P/E Ratio:
-0.7623
EPS:
-5.68
Net Cash Flow:
$-13.07M
1W Performance:
-20.11%
1M Performance:
+37.03%
6M Performance:
+9.07%
1Y Performance:
+88.24%
1-Day Range:
$4.15
$4.5008
1-Week Range:
$4.15
$5.5765
52-Week Range:
$1.97
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
4.33 | 26.62M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Detecting price anomalies in Vivos Therapeutics Inc. with AIROI Focused Watchlist with Trade Confidence - Newser
Short interest data insights for Vivos Therapeutics Inc.Stock Market Watch with Smart Filters - Newser
Can momentum traders help lift Vivos Therapeutics Inc.Earnings Report Summary with Market Impact - Newser
Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Climb 43% But Its Business Is Yet to Catch Up - 富途牛牛
What is the dividend policy of Vivos Therapeutics Inc. stockTop Growth Ideas To Watch Now - jammulinksnews.com
How volatile is Vivos Therapeutics Inc. stock compared to the marketSwing Trade Updates For Consistent Profits - jammulinksnews.com
Is Vivos Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Price Target Forecast and Alerts - Newser
Is Vivos Therapeutics Inc. stock poised for growthAlpha Generation Strategy with Low Volatility - Newser
How Efficient Is Vivos Therapeutics Inc. at Controlling Operating CostsFree Trade Timing Strategy With Technical Data - Newser
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth - GlobeNewswire
Vivos Therapeutics appoints two executives to support growth strategy - Investing.com Australia
Vivos Therapeutics appoints two executives to support growth strategy By Investing.com - Investing.com UK
How Interest Rate Changes Impact Vivos Therapeutics Inc. Stock PerformanceAsset Safety Selection Using Quantitative Analysis - Newser
Is Vivos Therapeutics Inc. reversing from oversold territoryTop Stock Picks with Forecast Accuracy - Newser
Published on: 2025-07-29 06:26:38 - Newser
Why is Vivos Therapeutics Inc. stock attracting strong analyst attentionSwing Trade Insights Backed By Experts - jammulinksnews.com
Vivos Therapeutics Inc. Stock Recovery Path — Analyst BreakdownLow Capital High Return Stock Plans Reviewed - beatles.ru
What catalysts could drive Vivos Therapeutics Inc. stock higher in 2025Unrivaled growth potential - jammulinksnews.com
Is Vivos Therapeutics Inc. stock overvalued or undervaluedHigh-octane financial growth - jammulinksnews.com
What is Vivos Therapeutics Inc. company’s growth strategyFree Wealth Planning Blueprint - jammulinksnews.com
What is the risk reward ratio of investing in Vivos Therapeutics Inc. stockBreakthrough financial growth - jammulinksnews.com
What are the latest earnings results for Vivos Therapeutics Inc.Invest smarter with comprehensive market analysis - jammulinksnews.com
Is it the right time to buy Vivos Therapeutics Inc. stockPhenomenal capital gains - jammulinksnews.com
Should I hold or sell Vivos Therapeutics Inc. stock in 2025Build a portfolio that withstands market volatility - jammulinksnews.com
Is Vivos Therapeutics Inc. stock a growth or value playHigh-profit capital plays - jammulinksnews.com
What analysts say about Vivos Therapeutics Inc. stockTremendous financial leverage - PrintWeekIndia
Is Vivos Therapeutics Inc. a good long term investmentExplosive market performance - PrintWeekIndia
Vivos Therapeutics Inc. Stock Analysis and ForecastConsistent high-performance stocks - Autocar Professional
Vivos’ Budget Oral Appliance Earns PDAC Verification - Sleep Review
What drives Vivos Therapeutics Inc. stock priceConsistently exceptional gains - jammulinksnews.com
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):